A Comparison of Psychotherapy and Pharmacotherapy in the Treatment of Erectile Dysfunction: A Pilot Study
Overview
- Phase
- N/A
- Intervention
- Cognitive Behavioral Psychotherapy
- Conditions
- Erectile Dysfunction
- Sponsor
- International Islamic University, Islamabad
- Enrollment
- 28
- Locations
- 1
- Primary Endpoint
- International Index of Erectile Functioning-5
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The study involved the administration of pharmacotherapy and cognitive behavior psychotherapy to individuals suffering from erectile dysfunction. The study was randomized controlled trial with two arms involving a control group. The study was conducted with an aim of pilot and feasibility study to evaluate the efficacy and suitability of cognitive behavior psychotherapy with individuals suffering from erectile dysfunction.
Investigators
Ahmad Bilal
Principal Investigator, PhD Research Candidate
International Islamic University, Islamabad
Eligibility Criteria
Inclusion Criteria
- •Men diagnosed with erectile dysfunction
- •Must be in the age range of 18 to 39 years
- •Must be in a stable heterosexual relationship
- •Must not be suffering from any medical or psychiatric illness
Exclusion Criteria
- •Men not meeting criteria of diagnosis of erectile dysfunction
- •Men not in a heterosexual relationship
- •Men of or above the age of 40 years
- •Men diagnosed with any medical or psychiatric illness or obese men
Arms & Interventions
Group A
The cognitive behavior psychotherapy was administered to participants in this treatment arm.
Intervention: Cognitive Behavioral Psychotherapy
Control Group
This group received the administration of pharmacotherapy (PDE5i) for treatment of Erectile Dysfunction.
Intervention: Sildenafil Citrate 50Mg Tab
Outcomes
Primary Outcomes
International Index of Erectile Functioning-5
Time Frame: 3 months maximum
The minimum scale score is 5. The maximum scale score is 25. The higher score indicates better erectile functioning.
Secondary Outcomes
- Depression, Anxiety, and Stress Scale-21(3 months maximum)